BOSTON--(BUSINESS WIRE)--Goodwin Procter, a leading Am Law 50 and Global 50 law firm, announced today that 23 attorneys have been elected to the firm’s partnership, effective Oct. 1.
“We are proud to recognize this newest generation of partners who have shown outstanding legal skills, market savvy and unrivaled collaboration among their peers,” said David Hashmall, chairman of Goodwin Procter. “We are delighted to welcome them to the partnership as we continue to deliver exceptional results for our clients.”
The newly elected partners are:
- Gregory T. Barclay (Private Investment Funds; London) advises on the formation of, and investment in, European and international private funds, including private equity, venture capital, mezzanine/debt, infrastructure and real estate funds, and other investment vehicles.
- William B. Brady (Securities Litigation & White Collar Defense; Boston) represents and advises clients in connection with a broad range of complex litigation matters, including class actions alleging violations of federal securities laws, shareholder derivative litigation, regulatory and internal investigations, and M&A-related litigation.
- Yvonne W. Chan (Business Litigation; Boston) represents clients in complex litigation matters, including post-merger disputes, shareholder litigations, SEC and FINRA investigations, and copyright and licensing disputes.
- James L. Donohue (Real Estate Capital Markets; Boston) advises on the structuring, formation and ongoing management of a variety of private investment funds, including real estate funds, private equity funds, venture capital funds and hedge funds, and their management companies.
- Mary K. Dulka (Securities Litigation & White Collar Defense; New York) represents mutual fund advisers, directors, securities issuers and underwriters in securities class actions and shareholder derivative actions.
- Ian D. Engstrand (Technology & Life Sciences; Boston) advises clients on matters including company formations, seed, venture and growth equity financings, mergers and acquisitions, capital markets transactions and compliance, and corporate governance, as well as the venture capital, private equity and investment banks that focus on these companies.
- Sarah K. Frederick (Specialty Litigation; Boston) represents defendants in complex products liability and antitrust cases at the trial and appellate levels and has considerable experience in the regulatory framework governing prescription pharmaceuticals.
- Mandee R. Gruen (Real Estate Capital Markets; New York) represents U.S. and international private investment funds, including real estate, private equity, infrastructure, debt and hedge funds, and their management companies in all aspects of their formation and ongoing operations.
- An-Yen E. Hu (Technology & Life Sciences; Silicon Valley) advises clients on general corporate matters for both private and public companies, securities laws, venture capital financings, mergers and acquisitions, public offerings, SEC compliance and corporate governance.
- Nilda M. Isidro (Specialty Litigation; New York) focuses her practice on products liability law, including mass torts and multi-district litigation. She also provides strategic counseling to a variety of food and supplement businesses on a broad range of issues, including regulatory compliance and litigation avoidance.
- Daniel A. Lang (Technology & Life Sciences; New York) advises a range of public and private companies on a wide variety of matters, including company formations, seed, venture and growth equity financings, M&A transactions, capital markets transactions and compliance, and corporate governance.
- James C.H. Lee (Private Equity; New York) advises private equity funds, venture capital funds, and privately held companies on domestic and cross-border mergers and acquisitions, recapitalization transactions, leveraged buyouts, acquisitions and divestitures, growth equity financings, securities offerings, joint venture transactions and corporate governance matters.
- Kunal Pasricha (Securities Litigation & White Collar Defense; Boston) advises clients in government and internal investigations, white-collar criminal defense, M&A-related litigation, securities litigation, and complex business litigation matters.
- David M. Patton (Tax; Boston) advises on tax aspects and structuring of private equity transactions, real estate and real estate related transactions, private investment funds, mergers and acquisitions, and other business transactions.
- David H. Roberts (Real Estate Capital Markets; Boston) represents public and private companies, including publicly traded REITs, non-publicly traded REITs and underwriters in transactions such as IPOs, follow-on and shelf offerings and 144A offerings of equity and debt securities.
- Joseph P. Rockers (Business Litigation; Boston) represents clients in complex commercial litigation in the trial courts and in arbitration. He also practices before federal and state appellate courts with regard to a broad array of commercial issues.
- Ryan S. Sansom (Technology & Life Sciences; Boston) represents privately held and publicly traded clients with an emphasis on emerging companies across the life sciences industry spectrum, including biotechnology, medical devices, HCIT and health and wellness, advising on public and private securities offerings, M&A and other complex transactions.
- Adam Slutsky (Securities Litigation & White Collar Defense; Boston) advises clients on securities and complex commercial litigation as well as shareholder disputes and disputes arising from corporate mergers and acquisitions.
- Adam P. Small (Private Equity; Boston) advises clients on leveraged buyouts and recapitalizations and private and public mergers and acquisitions as well as the general representation of privately and publicly held companies.
- Jared Spitalnick (Private Equity; New York) advises private equity funds and their portfolio companies in large scale and middle-market transactions, including mergers, stock and asset acquisitions and divestitures and growth equity investments.
- Laura A. Stoll (Consumer Financial Services Litigation; Los Angeles) focuses on complex commercial litigation matters, with particular emphasis on financial services litigation and class action defense.
- Jordan D. Weiss (Business Litigation; New York) concentrates on complex commercial litigation, partnership disputes, acquisition disputes and pharmaceutical antitrust litigation. He also has represents clients in intellectual property and product liability disputes.
- Calvin E. Wingfield, Jr. (IP Litigation; New York) advises on a broad range of intellectual property matters, including patent and trademark litigation, patent enforcement, and intellectual property counseling.
Goodwin Procter LLP is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 850 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at www.goodwinprocter.com. Follow us on Twitter @goodwinprocter.
